GT719 Injection for Moderate to Severe Refractory Autoimmune Diseases

NCT07122076 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Autoimmune Diseases

Interventions

BIOLOGICAL: GT719 Injection

Sponsor

Grit Biotechnology